Literature DB >> 22964562

Impact of estrogen replacement throughout childhood on growth, pituitary-gonadal axis and bone in a 46,XX patient with CYP19A1 deficiency.

Marco Janner1, Christa E Flück, Primus E Mullis.   

Abstract

BACKGROUND: The adequate replacement dose of estrogens during infancy and childhood is still not known in girls. Aromatase deficiency offers an excellent model to study how much estrogens are needed during infancy, childhood and adulthood.
OBJECTIVES: We studied the impact of oral 17β-estradiol treatment, on longitudinal growth, bone age maturation, pituitary gonadotropin feedback, multicystic ovaries and bone mass in the long-term follow-up of a girl compound heterozygote for two point mutations of the CYP19A1 gene.
RESULTS: Low doses of 17β-estradiol were needed to achieve normal height velocity and adequate bone age maturation from early childhood on. Serum estradiol levels needed for breast development and for the appearance of an endometrial reflex were not sufficient to achieve physiological gonadotropin levels. Without 17β-estradiol treatment the ovaries of the patient showed a multicystic appearance, which reversed on 17β-estradiol replacement. Bone mass was within normal ranges during the whole follow-up period.
CONCLUSION: In summary, we have shown that estradiol is needed not only in puberty but also in childhood for normal growth, bone maturation and achievement of normal bone mass. Particularly, this observation underscores the importance of early low-dose estrogen replacement also in other estrogen-deficient conditions as for instance in Turner's syndrome.
Copyright © 2012 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22964562     DOI: 10.1159/000341585

Source DB:  PubMed          Journal:  Horm Res Paediatr        ISSN: 1663-2818            Impact factor:   2.852


  7 in total

1.  Autologous transplantation of cryopreserved ovarian tissue to induce puberty-the endocrinologists' view.

Authors:  Michael von Wolff; Petra Stute; Christa Flück
Journal:  Eur J Pediatr       Date:  2016-09-15       Impact factor: 3.183

Review 2.  46,XX DSD due to Androgen Excess in Monogenic Disorders of Steroidogenesis: Genetic, Biochemical, and Clinical Features.

Authors:  Federico Baronio; Rita Ortolano; Soara Menabò; Alessandra Cassio; Lilia Baldazzi; Valeria Di Natale; Giacomo Tonti; Benedetta Vestrucci; Antonio Balsamo
Journal:  Int J Mol Sci       Date:  2019-09-17       Impact factor: 5.923

3.  Aromatase Deficiency in Two Siblings with 46,XX Karyotype Raised as Different Genders: A Novel Mutation (p.R115X) in the CYP19A1 Gene

Authors:  Samim Özen; Tahir Atik; Özlem Korkmaz; Hüseyin Onay; Damla Gökşen; Ferda Özkınay; Özgür Çoğulu; Şükran Darcan
Journal:  J Clin Res Pediatr Endocrinol       Date:  2019-04-10

4.  Novel CYP19A1 Mutations Extend the Genotype-Phenotype Correlation and Reveal the Impact on Ovarian Function.

Authors:  Valiyaparambil Pavithran Praveen; Asmahane Ladjouze; Kay-Sara Sauter; Annie Pulickal; Efstathios Katharopoulos; Mafalda Trippel; Aurel Perren; Amit V Pandey; Christa E Flück
Journal:  J Endocr Soc       Date:  2020-03-10

5.  A Novel Homozygous CYP19A1 Gene Mutation Causing Aromatase Deficiency.

Authors:  Deep Hathi; Soumik Goswami; Nilanjan Sengupta; Arjun Baidya
Journal:  Cureus       Date:  2022-02-09

6.  A case of Aromatase deficiency due to a novel CYP19A1 mutation.

Authors:  Lucia Gagliardi; Hamish S Scott; Jinghua Feng; David J Torpy
Journal:  BMC Endocr Disord       Date:  2014-02-19       Impact factor: 2.763

7.  Aromatase Deficiency due to a Novel Mutation in CYP19A1 Gene

Authors:  Edip Unal; Ruken Yıldırım; Funda Feryal Taş; Vasfiye Demir; Hüseyin Onay; Yusuf Kenan Haspolat
Journal:  J Clin Res Pediatr Endocrinol       Date:  2018-03-19
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.